CN Patent

CN110215435A — 一种制备多囊脂质体的方法

Assigned to GUANGDONG JIABO PHARMACEUTICAL Co Ltd · Expires 2019-09-10 · 7y expired

What this patent protects

本发明公开了一种制备粒度均一的多囊脂质体的方法，通过将第一相W/O乳液经过多孔膜分散到第二相水溶液，形成高质量单分散稳定的W/O/W乳液，进一步除去复乳中挥发性溶剂可以制得含有多囊脂质体的组合物。根据本发明的方法可以获得粒径分布范围窄的多囊脂质体。

USPTO Abstract

本发明公开了一种制备粒度均一的多囊脂质体的方法，通过将第一相W/O乳液经过多孔膜分散到第二相水溶液，形成高质量单分散稳定的W/O/W乳液，进一步除去复乳中挥发性溶剂可以制得含有多囊脂质体的组合物。根据本发明的方法可以获得粒径分布范围窄的多囊脂质体。

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: CN110215435A
Jurisdiction: CN
Classification: —
Expires: 2019-09-10
Drug substance claim: No
Drug product claim: No
Assignee: GUANGDONG JIABO PHARMACEUTICAL Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.